Skip to main content
. 2022 Dec 20;13:1095915. doi: 10.3389/fimmu.2022.1095915

Figure 1.

Figure 1

Mechanism of liver cancer immunotherapy mediated by OCA and 5β-CA. OCA binds to FXR and 5β-CA binds to TGR5, thus upregulating CXCL16 secretion from LSEC. The increase in CXCL16 promotes NKT cell accumulation in the liver and tumor-suppressive effects.